[{"Assets_0_Q3_USD":254136000.0,"CommonStockSharesOutstanding_0_Q3_shares":149688000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-55810000.0,"NetIncomeLoss_1_Q3_USD":-21750000.0,"NetIncomeLoss_3_Q3_USD":-108947000.0,"StockholdersEquity_0_Q3_USD":-86225000.0,"Ticker":"IMGN","CIK":"855654","name":"IMMUNOGEN, INC.","OfficialName":"ImmunoGen Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1148965984.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191105"}]